NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a global coalition is preparing to shift the spotlight from the traditional "pink" narrative toward a more sobering and urgent reality. On October 13, 2026, designated as National Metastatic Breast Cancer Awareness Day, more than 325 landmarks across the globe will be illuminated in the symbolic colors of teal, green, and pink. This massive visual undertaking, organized by METAvivor Research and Support, forms the backbone of the #LightUpMBC campaign—a global initiative designed to advocate for the estimated hundreds of thousands of people living with Stage 4 breast cancer.
Main Facts: A Global Illumination for a Terminal Cause
The #LightUpMBC campaign is not merely a display of lights; it is a coordinated effort to raise funds for research that remains critically underfunded. While traditional breast cancer campaigns often focus on early detection and "curing" the disease, metastatic breast cancer (MBC) currently has no cure. It is the stage of the disease where the cancer has spread beyond the breast to vital organs such as the bones, liver, lungs, or brain.
On the evening of October 13, landmarks in all 50 U.S. states and across 20 countries—spanning 195 cities—will change their lighting schemes. Notable participants include One World Trade Center in New York City, the Willis Tower in Chicago, Philadelphia City Hall, and international sites like the Mactan-Cebu Airport in the Philippines and the Ness Bridge in Inverness, Scotland.
The campaign culminates in #LightUpMBC Live, a high-production virtual broadcast beginning at 8 p.m. ET / 5 p.m. PT. The program is designed to bridge the gap between the aesthetic beauty of the illuminated landmarks and the lived experiences of patients. Hosted by Tami Eagle Bowling, an 11-year MBC survivor and campaign creator, and Broadway star Kara Lindsay, the event will feature a mix of scientific briefings, patient testimonials, and performances by Tony Award-winning artists.
Crucially, 100% of the net proceeds generated from the campaign and the livestream are channeled directly into Stage 4 research grants. METAvivor remains the only national organization in the United States that exclusively funds research for metastatic breast cancer, filling a gap in a philanthropic landscape where only an estimated 2-5% of overall breast cancer research funding is dedicated to the metastatic stage.
Chronology: From a Single Bridge to a Global Network
The evolution of #LightUpMBC is a testament to the power of patient advocacy and the legacy of those lost to the disease. The movement traces its origins back to 2017, when the first landmark—the Memorial Bridge in Portsmouth, New Hampshire—was lit to honor Jessica Moore.
Jessica Moore was a young woman diagnosed with MBC who recognized a profound disconnect between the "pink ribbon" culture and the reality of her terminal diagnosis. Her vision was simple: to have one local landmark recognize the specific struggle of metastatic patients. Following her death at the age of 36, her best friend, Laura Inahara, took up the mantle.
What began as a localized tribute quickly resonated with the MBC community, which often feels sidelined during October’s "pink-washing" festivities. By 2019, the campaign had expanded to several dozen cities. By 2021, it had crossed international borders.
By 2026, the campaign has achieved unprecedented scale. The growth from a single bridge in New Hampshire to 325 landmarks worldwide reflects a shift in public consciousness. The timeline of the movement shows a steady progression from grief-driven advocacy to a sophisticated, multi-million-dollar fundraising engine. To date, the #LightUpMBC initiative has raised over $2.7 million, providing a lifeline for researchers searching for the next breakthrough in targeted therapies.
Supporting Data: The Stark Reality of MBC in 2026
The urgency of the #LightUpMBC campaign is underscored by harrowing statistics provided by the National Cancer Institute and the American Cancer Society. In 2026, it is estimated that 42,670 people in the United States will lose their lives to breast cancer. This averages out to approximately 117 deaths every single day.
Virtually all of these deaths are the result of metastatic disease. While the five-year survival rate for localized breast cancer (Stage 1) is near 99%, the five-year survival rate for those diagnosed with distant metastatic disease (Stage 4) remains significantly lower, hovering around 30%, despite advancements in treatment.
The Biological Challenge
MBC is not a separate disease but the progression of the original breast cancer cells. These cells can lie dormant for years or even decades. Data shows that:
- Approximately 6% of new breast cancer diagnoses are "de novo" metastatic, meaning the cancer has already spread by the time it is first discovered.
- Up to 30% of women diagnosed with early-stage breast cancer will eventually see their cancer return as metastatic, regardless of the success of their initial treatments.
- Treatment for MBC is lifelong. There is no "finishing" treatment; instead, patients remain on various lines of therapy until the cancer develops resistance, at which point they must switch to a new drug.
The #LightUpMBC campaign uses the colors teal, green, and pink to represent these specific challenges. Teal symbolizes healing and spirituality; green represents the triumph of spring over winter and the hope of renewal; and the thin pink ribbon signifies the breast cancer origin.
Official Responses: Voices from the Frontlines
The leadership at METAvivor emphasizes that while the lights are a beautiful tribute, the ultimate goal is survival.
Dr. Kelly Shanahan, the Board President of METAvivor, provides a unique perspective as both a physician and a patient. Diagnosed with MBC in 2013, Dr. Shanahan has defied the average statistics for over a decade. “When I was diagnosed, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community.”
Laura Inahara, the founder of the campaign, highlights the emotional weight behind the movement. “Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research.”
Tami Eagle Bowling, who has lived with the disease for 11 years, views the livestream as a vital educational tool. “We need to meet the people behind the lights,” Bowling said. “The program features patient stories shared live from these illuminated landmarks. It’s about putting a face to the statistics and showing the world that we are still here, we are still fighting, but we need more options.”
The scientific community also acknowledges the role of METAvivor’s funding. Because the organization uses a rigorous peer-review process involving both scientists and patient advocates, the grants often go to "high-risk, high-reward" projects that traditional government funding might overlook.
Implications: Changing the Narrative of Breast Cancer
The #LightUpMBC campaign has significant implications for how society perceives and treats breast cancer. For decades, the public health message has been "early detection saves lives." While true for many, this message inadvertently creates a stigma for those whose cancer was detected early but still metastasized, or those who were diagnosed at Stage 4 from the start.
1. Shifting the Philanthropic Focus
The success of #LightUpMBC is forcing a re-evaluation of where "pink" dollars go. As more people realize that nearly 100% of breast cancer deaths are caused by metastasis, there is increasing pressure on larger breast cancer charities to allocate a higher percentage of their budgets to Stage 4 research rather than just awareness and screening.
2. Building a Global Support Network
The inclusion of landmarks in countries like the Philippines and Scotland signifies the globalization of MBC advocacy. Metastatic breast cancer is a universal crisis, and by lighting landmarks globally, the campaign fosters a sense of solidarity among patients who often feel isolated by their terminal status.
3. Enhancing Patient Literacy
Through the #LightUpMBC Live stream, patients are exposed to the latest scientific perspectives. This empowers them to have more informed conversations with their oncologists about clinical trials and emerging therapies, such as antibody-drug conjugates (ADCs) and immunotherapy, which are currently at the forefront of MBC research.
4. The "Survivable Condition" Goal
The ultimate implication of the campaign is the potential transformation of MBC. METAvivor’s mission is to move the needle from "terminal" to "chronic." Much like the management of HIV/AIDS in the 1990s, the hope is that through sustained research funding, MBC can become a survivable condition where patients can maintain a high quality of life for decades.
As the sun sets on October 13, 2026, the glow of teal, green, and pink across 325 landmarks will serve as a lighthouse for the MBC community. It is a visual reminder that while the pink ribbon represents the start of the journey for many, the fight for the lives of the 117 people dying every day requires a different kind of light—one fueled by research, advocacy, and an unwavering refusal to be overshadowed.
How to Participate:
The public is encouraged to take photos of participating landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor, tagging @LightUpMBC. For a full list of landmarks and to access the livestream, visit www.lightupmbc.org.
About the Author
